Cargando…

A novel risk model for mortality and hospitalization following cardiac resynchronization therapy in patients with non-ischemic cardiomyopathy: the alpha-score

BACKGROUND: Non-ischemic cardiomyopathy (NICM) has been associated with a better left ventricle reverse remodeling response and improved clinical outcomes after cardiac resynchronization therapy (CRT). The aims of our study were to identify the predictors of mortality and heart failure hospitalizati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Shengwen, Liu, Zhimin, Hu, Yiran, Jing, Ran, Gu, Min, Niu, Hongxia, Ding, Ligang, Xing, Anlu, Zhang, Shu, Hua, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189497/ https://www.ncbi.nlm.nih.gov/pubmed/32345229 http://dx.doi.org/10.1186/s12872-020-01460-x

Ejemplares similares

Plasma Metabolomic Profiles Differentiate Patients With Dilated Cardiomyopathy and Ischemic Cardiomyopathy
por: Zhao, Junhan, et al.
Publicado: (2020)

A Predictive Model for Super-Response to Cardiac Resynchronization Therapy: The QQ-LAE Score
por: Liu, Xi, et al.
Publicado: (2020)

A prognostic nomogram for event-free survival in patients with atrial fibrillation before cardiac resynchronization therapy
por: Cai, Minsi, et al.
Publicado: (2020)

Comprehensive plasma metabolites profiling reveals phosphatidylcholine species as potential predictors for cardiac resynchronization therapy response
por: Yang, Shengwen, et al.
Publicado: (2020)

Cardiac resynchronization therapy in ischemic and non-ischemic cardiomyopathy
por: Yokoshiki, Hisashi, et al.
Publicado: (2017)

Association Between Subcutaneous Implantable Cardioverter Defibrillator Preimplantation Screening and the Response to Cardiac Resynchronization Therapy
por: Jing, Ran, et al.
Publicado: (2020)

Non-ischemic Cardiomyopathy Patients Derive Superior Mortality Benefit from Cardiac Resynchronization Therapy
por: Rosman, Jonathan, et al.
Publicado: (2007)

Prognostic effects of longitudinal changes in left ventricular ejection fraction with cardiac resynchronization therapy
por: Zhang, Nixiao, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy in Non-Ischemic Cardiomyopathy: Role of Multimodality Imaging
por: Stătescu, Cristian, et al.
Publicado: (2021)

Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy
por: Gu, Min, et al.
Publicado: (2017)

Cardiac resynchronization therapy pacemakers versus defibrillators in older non-ischemic cardiomyopathy patients
por: Wang, Yanting, et al.
Publicado: (2018)

Abnormal diastolic function underlies the different beneficial effects of cardiac resynchronization therapy on ischemic and non-ischemic cardiomyopathy
por: Wang, Qi, et al.
Publicado: (2017)

Assessment of Metabolic Phenotypes in Patients with Non-ischemic Dilated Cardiomyopathy Undergoing Cardiac Resynchronization Therapy
por: Obrzut, Sebastian, et al.
Publicado: (2010)

Electro-echocardiographic Indices to Predict Cardiac Resynchronization Therapy Non-response on Non-ischemic Cardiomyopathy
por: Yu, Ziqing, et al.
Publicado: (2017)

Increased mortality and ICD therapies in ischemic versus non-ischemic dilated cardiomyopathy patients with cardiac resynchronization having survived until first device replacement
por: Beiert, Thomas, et al.
Publicado: (2018)

Cardiac resynchronization in pacing-associated cardiomyopathy: Is it time to upgrade?
por: Hutchinson, Mathew D.
Publicado: (2021)

Defibrillator capability and all-cause mortality in patients receiving cardiac resynchronization therapy for non-ischemic cardiomyopathy: a Korean nationwide cohort study
por: Yang, P S, et al.
Publicado: (2023)

Arrhythmic and mortality outcomes in patients with dilated cardiomyopathy receiving cardiac resynchronization therapy without defibrillator
por: Samy, Mohammed, et al.
Publicado: (2023)

Echocardiographic Predictors of All-Cause Mortality in Patients with Hypertrophic Cardiomyopathy following Pacemaker Implantation
por: Zhang, Nixiao, et al.
Publicado: (2020)

Cardiac Resynchronization Therapy and Hypertrophic Cardiomyopathy: A Comprehensive Review
por: Radu, Andrei Dan, et al.
Publicado: (2023)

Length of Hospitalization-Related Differences and Associated Long-Term Prognosis of Patients with Cardiac Resynchronization Therapy: A Propensity Score-Matched Cohort
por: Yu, Yu, et al.
Publicado: (2022)

Independent and Joint Association of Statin Therapy with Adverse Outcomes in Heart Failure Patients with Atrial Fibrillation Treated with Cardiac Resynchronization Therapy
por: Yu, Yu, et al.
Publicado: (2022)

LV Dyssynchrony Is Helpful in Predicting Ventricular Arrhythmia in Ischemic Cardiomyopathy After Cardiac Resynchronization Therapy: A Preliminary Study
por: Tsai, Shih-Chuan, et al.
Publicado: (2016)

Adaptive cardiac resynchronization therapy for dilated cardiomyopathy with functional mitral regurgitation
por: Nagata, Yoshiki, et al.
Publicado: (2017)

Peripartum cardiomyopathy and cardiac resynchronization therapy: Case reports and literature review
por: Wang, Norman C., et al.
Publicado: (2021)

Ischemic Etiology and Clinical Outcomes Following Cardiac Resynchronization Therapy
por: Imamura, Teruhiko
Publicado: (2020)

Dilemma with the route of venous access for hemodialysis catheter insertion in a patient with dilated ischemic cardiomyopathy treated by cardiac resynchronization therapy
por: Ashokananda, Devanahalli, et al.
Publicado: (2016)

Effectiveness of adding a defibrillator with cardiac resynchronization therapy in heart failure according to the modified Model for End-stage Liver Disease-Albumin score
por: Cheng, Sijing, et al.
Publicado: (2023)

Cardiac resynchronization therapy using left ventricular septal pacing: An alternative to biventricular pacing?
por: Gu, Min, et al.
Publicado: (2019)

Cardiac Resynchronization Therapy in Infant with Dilated Cardiomyopathy during Extracorporeal Membrane Oxygenator
por: Bang, Ji Hyun, et al.
Publicado: (2015)

The therapeutic benefit of upgrade to cardiac resynchronization therapy in patients with pacing-induced cardiomyopathy
por: Kerley, Robert N., et al.
Publicado: (2023)

Response to Cardiac Resynchronization Therapy in Cardiomyopathy Patients with Right Bundle Branch Block
por: Zand, Sara, et al.
Publicado: (2023)

Risk scores in cardiac resynchronization therapy–A review of the literature
por: Boros, András Mihály, et al.
Publicado: (2023)

Machine learning-based mortality prediction of patients undergoing cardiac resynchronization therapy: the SEMMELWEIS-CRT score
por: Tokodi, Márton, et al.
Publicado: (2020)

EAARN score, a predictive score for mortality in patients receiving cardiac resynchronization therapy based on pre-implantation risk factors
por: Khatib, Malek, et al.
Publicado: (2014)

Cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy: long-term follow up
por: de Araújo, Edgard Ferreira, et al.
Publicado: (2014)

Efficacy and safety of cardiac resynchronization therapy in chemotherapy‐induced cardiomyopathy: A systematic review
por: Shehram, Muhammad, et al.
Publicado: (2023)

An updated meta-analysis of cardiac resynchronization therapy with or without defibrillation in patients with nonischemic cardiomyopathy
por: Liu, Fuwei, et al.
Publicado: (2023)

Mortality and Heart Failure After Upgrade to Cardiac Resynchronization Therapy
por: Beca, Bogdan, et al.
Publicado: (2019)

Predicting the survival benefit of cardiac resynchronization therapy with defibrillator function for non-ischemic heart failure—Role of the Goldenberg risk score
por: Merkel, Eperke D., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_14cvoi5se3b5g61sgkmdqkl87f